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A previous report of a novel pneumovirus (PnV) isolated from the respiratory tract of a dog described its
signiﬁcant homology to the rodent pathogen, pneumonia virus of mice (PVM). The original PnV–Ane4
pathogen replicated in and could be re-isolated in infectious state from mouse lung but elicited minimal
mortality compared to PVM strain J3666. Here we assess phylogeny and physiologic responses to 10 new
PnV isolates. The G/glycoprotein sequences of all PnVs include elongated amino-termini when compared to
the characterized PVMs, and suggest division into groups A and B. While we observed signiﬁcant differences
in cytokine production and neutrophil recruitment to the lungs of BALB/c mice in response to survival doses
(50 TCID50 units) of representative group A (114378-10-29-KY-F) and group B (7968-11-OK) PnVs, we
observed no evidence for positive selection (dN4dS) among the PnV/PnV, PVM/PnV or PVM/PVM G/
glycoprotein or F/fusion protein sequence pairs.
Published by Elsevier Inc.Introduction
A novel pneumovirus (PnV), originally called canine pneumo-
virus, was isolated by Renshaw et al. (2010, 2011) as a part of a larger
effort to identify respiratory pathogens from dogs. The original
isolate (Ane4) elicited a unique cytopathic effect in A72 canine
ﬁbroblasts, showed reactivity with pooled monoclonal antibodies
against human respiratory syncytial virus (hRSV), and was found to
be highly homologous (490% overall nucleotide sequence homol-
ogy) to the rodent pneumovirus pathogen, pneumonia virus of mice
(PVM). While relatively little is known about rodent pneumovirus
infection in the wild (Kaplan et al., 1980; Greenwood and Sanchez,
2002; Smith et al., 1993; Becker et al., 2007; Descoteaux and Mihok,
1986; Drexler et al. 2012), PVM has been reported with signiﬁcant
frequency in research and commercial rodent colonies in both
mouse and rat sentinels (Liang et al., 2009; Zenner and Regnault
2000; Miyata et al., 1995). PVM strain J3666 has been developed as a
model for the study of acute pneumovirus infection in vivo
(Rosenberg and Domachowske, 2008; Bem et al., 2011), as it is
highly virulent for almost all inbred mouse strains (Anh et al., 2006)
and elicits clinical symptoms and pathophysiology similar to severe
hRSV disease in humans (Rosenberg and Domachowske, 2012). In
contrast, the two PVM strain 15 s (str15/warwick and str 15/atcc)
differ somewhat in terms of responses elicited in vivo (reviewed in
(Dyer et al., 2012)). PVM Y is a fully independent isolate, originallyInc.
senberg).
s work.derived from a spontaneous infection in athymic mice (Weir et al.,
1988; Roths, et al., 1993).
The contributions of PnVs to respiratory tract disease in canine
species have not yet been fully explored. However, PnV–Ane4 fulﬁlls
Koch's postulates for a microbial pathogen in rodent species, speci-
ﬁcally: (1) isolated PnV–Ane4 can be introduced into healthy BALB/c
mice where it elicits disease, (2) PnV–Ane4 can be isolated in
abundance from the lungs of diseased BALB/c mice and identiﬁed
ex vivo, in tissue culture, and (3) isolated PnV–Ane4 grown from
tissue culture can be re-introduced into new, healthy BALB/c mice,
where they again elicit disease (Percopo et al., 2011; data not shown).
In this manuscript, we examine 10 new PnVs isolated from the
respiratory tracts of both canine and feline species from various
locations in the continental United States. An evaluation of PnV
G/glycoprotein-encoded amino acid sequence led us to deﬁne PnV
groups A and B, which are phylogenetically distinct from the
currently characterized PVMs. Given this ﬁnding, we have exam-
ined virus replication and cellular and biochemical inﬂammation
elicited by representatives from each of the two PnV groups in
order to ascertain whether there are speciﬁc responses to poten-
tially distinct viral determinants.Results and discussion
Sequence comparisons between PVMs and PnVs
This analysis includes the encoded (full-length) amino acid
sequences of the G/glycoproteins of the 11 independent PnVs,
Fig. 1. Novel PnV sequences. (A) Amino termini of G/glycoprotein sequences of pneumonia virus of mice (PVM; strain 15/warwick, strain 15/atcc, J3666, Y, Genbank nos.
AY743910, AY729016, NC_00657, and JQ899033, respectively) and pneumoviruses (PnV, 11 independent isolates, Genbank acc. no. KC495958-KC495967; see also
Supplemental Table 1). In blue, the intracellular domain of the G/glycoprotein sequence of human respiratory syncytial virus (hRSV strain 19, Genbank FJ614813). Asterisks
indicate points of full sequence identity between all viruses shown. (B) Unrooted Neighbor-joining tree (Nei-Gojobori, 2000 bootstrap replicates) with full-length
G/glycoprotein amino acid sequences. Three independent clusters, PnV—group A, PnV—group B and PVM are deﬁned as shown. (C) Parallel analysis of F/fusion protein
sequences (Genbank acc. nos. KC603765–KC603767) supports the cluster divisions generated in (B). PVM and PnVs shown in blue and underlined are featured in this
manuscript or in Percopo et al. (2011).
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denoted by its original code, 114296-08-NY) and the 4 character-
ized G/glycoprotein sequences from the known PVMs. Of note,
G/glycoprotein sequence divergence of the human pneumoviruspathogen, hRSV, deﬁnes the epidemiologic groups A and B and
provides the basis for most molecular studies (reviewed in
(Johnson et al., 1987; Garcia et al., 1994; Venter et al., 2001)).
Likewise, the G/glycoproteins include most of the sequence
Fig. 2. Survival analysis. (A) Survival of mice inoculated with PnV group A 114378-
10-29-KY on day 0, n¼7–8 mice per group. (B) Survival of mice inoculated with
PnV group B 7968-11-OK on day 0, n¼5 mice per group. All inoculations were in a
50 μL volume; TCID50 assay as described in Materials and methods.
Fig. 3. Virus recovery. Virus recovery from mice inoculated with 50 TCID50 units
(A) PnV 114378-10-29-KY or (B) PnV 7698-11-OK on day 0. Recovery on days 3, 5,
6 and 7 after inoculation determined by dual standard curve qRT-PCR
(Gabryszewski et al., 2011); dashed horizontal line is limit of detection of the
assay, n¼6–7 mice per time point.
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(Randhawa et al., 1995; Thorpe and Easton, 2005; Krempl et al.,
2005).
Overall, the homology between the G/glycoproteins of the
PVMs and the PnVs is high. Comparison of amino acid sequences
of 44 independent full-length pairs (4 from the PVMs vs. 11 from
the PnVs) yields a value of 90.371.7% sequence identity.
Renshaw and colleagues (2011) reported that the G/glycopro-
tein encoded by the initial isolate, 114296-08-NY, included an
extended amino terminus when compared to PVM J3666 and PVM
str15/atcc. We show here that these 18 additional N-terminal
amino acids are found in all 11 PnV variants (Fig. 1A). By analogy
with the characterized structure of the hRSV G/glycoprotein, these
amino termini extend the cytoplasmic/intracellular region of this
protein. Interestingly, there is clearly some inherent plasticity at
this site, as the amino terminus of PVM strain 15/warwick is
substantially truncated compared to the other PVMs and PnVs
(Krempl and Collins, 2004; Krempl et al., 2007).
Shown in Fig. 1B is an unrooted Neighbor-joining tree display-
ing the relationships among the PnV and PVM G/glycoproteins.
Overall, this analysis provides strong statistical support for divi-
sion of PnVs into two groups, which we have named groups A and
B, each distinct from one another and from a third group that
includes all currently characterized PVMs. Group A includes the
two isolates from New York together with independent isolates
from Ohio, Nevada, Massachusetts and Kentucky. Group B includes
new isolates from Pennsylvania, Texas, Oklahoma, Kansas and
Washington, D.C. Comparable results were obtained from the
analysis of available PnV and PVM F/fusion protein gene sequences
(Fig. 1C). The divergence of the PVMs from the PnVs might be
anticipated, as all currently characterized PVMs were originally
isolated from laboratory mice, 20 and 70 years ago (Horsfall and
Hahn, 1940; Weir et al., 1988). In contrast, there are no obvious
reasons that explain why the recently-characterized PnVs segre-
gate into two distinct groups. Group A and group B PnVs were
identiﬁed at multiple locations in the U.S. and throughout the
study period (Supplemental Table 1). The speciﬁc sites of amino
acid sequence divergence that distinguish the three groups (PVM
vs. PnV group A vs. PnV group B) are distributed over the full
length of the G/glycoprotein polypeptide, although they are at
highest density near the carboxy terminus (Supplemental Fig. 1).
Responses of BALB/c mice to inoculation with CnPnVs 114378-10-29-
KY-F and 7698-11-OK
Given these observations, our intent was to compare the
responses of BALB/c mice to parallel challenge with a representa-
tive group A (114378-10-29-KY-F) and group B (7968-11-OK) PnV.
Similar to our initial ﬁndings with PnV–Ane4 (114296-08-NY from
group A; Percopo et al., 2011), all of the mice challenged with 50
TCID50 units or fewer of either PnV survive (Fig. 2) and seroconvert
(data not shown). PnV 7968-11-OK is somewhat more virulent
than PnV 114378-10-29-KY-F (LD90s calculated at 180 and 800
TCID50 units, respectively). However, both PnVs are dramatically
less virulent than PVM J3666, in which inocula of 0.5 and 0.17
TCID50 units (100- to 300-fold fewer than those used here)
promote a uniformly fatal infection in BALB/c mice (Percopo
et al., 2011).
Virus replication and production of proinﬂammatory mediators
in lung tissue were assessed in response to sublethal inocula (50
TCID50 units/50 mL) of each PnV. Virus replication was detected as
early as day 3 after initial intranasal challenge, with peak levels
observed at day 6 post-inoculation, determined using a dual
standard curve quantitative PCR method that provides absolute
calibration of both the virus SH gene and the cellular GAPDH
(Gabryszewski et al., 2011; Fig. 3). No virus was recovered fromlung tissue of mice challenged with an equivalent inoculum of
heat-inactivated virions (data not shown).
Virus replication was associated with local production of
proinﬂammatory cytokines, including CCL3 (MIP-1α), CXCL1 (KC),
CXCL-10 (IP-10), CCL2 (MCP-1), and IFNγ (Fig. 4). Proinﬂammatory
cytokines were detected over background levels at day 5 to 6, and
remained elevated through day 7 after inoculation. Interestingly,
we found that cytokine responses to PnV-7968-11-OK were sig-
niﬁcantly diminished (pg/mg lung protein) overall compared to
Fig. 4. Detection of proinﬂammatory cytokines. Lung homogenates were prepared from mice inoculated with 50 TCID50 units PnV 114378-10-29-KY or PnV 7698-11-OK
and subjected to ELISA, with values corrected for total protein to detect (A) MIP-1α/CCL3 (B) KC/CXCL1 (C) IP-10/CCL10 (D) MCP-1/CCL2 and (E) IFNγ; n¼6–7 mice per time
point. Shown are the means +/− SEM, npo0.05, nnpo0.01, nnnpo0.001, two way ANOVA with Bonferroni's multiple comparisons test.
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inoculum. No signiﬁcant cytokine production was detected in lung
tissue from mice challenged with an equivalent inoculum of heat-
inactivated virions (data not shown). As shown in Fig. 5, transcrip-
tion of IFN-β was induced by both PnVs, although no immunor-
eactive IFN-β protein was detected at any time point. Expression of
IFNβ transcript in the absence of detectable protein was observed
in mice infected with PVM J3666, while immunoreactive inter-
feron-alpha remained prominent (Garvey et al., 2005). Pneumo-
virus nonstructural proteins NS-1 and NS-2 have been explored as
virus-mediated interferon-antagonists (Schlender et al., 2000;
Spann et al., 2004; Heinze et al., 2011), although the precise mec-
hanism remains uncertain.PnV infection was associated with mild multifocal pneumonia
(Fig. 6A and B), with peribronchiolar and perivascular cellular
inﬁltrates, composed mainly of neutrophils (Fig. 6C and D). No
hemorrhage or edema was observed. Neutrophils were detected in
bronchoalveolar (BAL) ﬂuid, a greater percentage detected in
response to PnV 114378-10-29-KY vs. PnV 7968-11-OK (Fig. 6E)
correlating with the differential cytokine responses.
Thus, both representative group A and group B PnVs selected for
study replicate in mouse lung tissue and elicit cytokine production
and neutrophil recruitment to the airways. We observed some
differential responses between representative group A and group B
PnVs that merit further consideration, although the general pat-
terns observed were consistent with those reported previously in
Fig. 5. Expression of transcripts encoding IFNβ. RNA from lungs of mice
inoculated with 50 TCID50 units PnV 114378-10-29-KY or PnV 7698-11-OK were
evaluated by qRT-PCR for IFNβ; n¼6–7 mice per time point, **po0.01, two-way
ANOVA with Bonferroni's multiple comparisons test.
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08-NY (Percopo et al., 2011). Overall, PnVs as a group elicit a
relatively mild inﬂammatory response with substantially less mor-
tality per TCID50 unit compared to PVM J3666.
Evolutionary constraints promoting diversity among PnVs and PVMs
As a means of assessing the evolutionary constraints promoting
divergence of the PnVs from one another and the PnVs from the
PVMs, the rates of nonsynonymous (dN¼n/N) and synonymous
substitution (dS¼s/S) were evaluated between all nucleotide
sequence pairs encoding the G/glycoproteins (Fig. 7A). Save for
the few pairs with minimal inter-sequence divergence (i.e., both dN
and dSo0.01), dN/dS was below unity (o1.0) throughout. As such,
the analysis provides no evidence for positive selection, i.e., there
are no apparent constraints serving to promote the rate of non-
synonymous nucleotide substitution over that of synonymous
(silent) substitution between any of these sequence pairs. The same
result (dN/dSo1.0) was found in a smaller comparison of pairs of
nucleotide sequences encoding the F/fusion protein (Fig. 7B).Conclusions
Our work characterizes novel pneumovirus variants (PnVs) that
are phylogenetically distinct from the four characterized variants
of pneumonia virus of mice (PVM). These PnVs were originally
isolated from the respiratory tracts of dogs and cats, although the
nature of the relationship between these hosts and the PnV
pathogen remains under investigation. Interestingly, all PnVs
evaluated thus far can elicit disease in BALB/c mice, although they
are substantially less virulent per tissue-culture infectious dose
(TCID50) unit when compared to inﬂammatory pathology and
mortality elicited by PVM J3666.Materials and methods
Isolation and sequencing of the G/glycoprotein genes of PnV variants
Virus culture and RNA extraction were as described (Renshaw
et al. (2011)). Reverse transcription PCR (RT-PCR) was performed in
a one-step reaction (Qiagen #210212) according to the manufac-
turer's instructions in a 25 mL volume with 1 mL of total RNA that
had been diluted 1:5–1:10 and 10 pmol of each primer (Supple-
mental Table 2). Reaction conditions were reverse transcription at
50 1C for 30 min, inactivation/denaturation at 95 1C for 15 min, and40 cycles of 30 s at 95 1C, 30 s at 52 1C, and 2 min at 72 1C. Products
were examined by agarose gel electrophoresis and sequenced
using an Applied Biosystems 3730 DNA analyzer. G/glycoprotein
sequences were submitted to Genbank under accession numbers
KC495958-KC495967.
Isolation and sequencing of the F/fusion genes of PnV variants
RNA was prepared from infected lung mouse tissue as pre-
viously described (Gabryszewski et al., 2011). Reverse transcrip-
tion was performed using a ﬁrst-strand cDNA synthesis kit
(Invitrogen, kit #11146-016) with random primers. Nested PCR
ampliﬁcation reactions were done according to the manufacturer's
instructions in a 50 μL volume (Invitrogen, kit #11708-13). Primers
sets used for ampliﬁcation include forward and reverse primers 5′-
TGT GCA GAC TCA GCT GGC CTA G-3′and 5′-AGC AAC GCA GAG
GAC GTC AAT T-3′ and forward and reverse nested primers 5′-ACC
CCC GCA CCT AGG AGG TC-3′ and 5′-TCA AGG GTT TTG TTC CAG
AGG GAG G-3′; all were designed based on PVM J3666 F gene
sequence (GenBank NC006579). Cycling parameters included a
hold at 94 1C for 2 min, followed by 40 cycles of 94 1C for 15 s,
50 1C for 30 s, and 68 1C for 2.5 min and 2 min for the ﬁrst and
second reactions, respectively, followed by a 6-min hold at 68 1C.
PCR products were sequenced using an Applied Biosystems 3130
DNA analyzer. Primers used to determine the complete sequence
were based on PnV-Ane4/114296-08-NY sequence (GenBank
HQ734815). Overlapping PCR products were generated to cover
gaps and binding regions. All regions were sequenced in both
directions. F/fusion sequences were submitted to Genbank under
accession numbers KC603765–KC603767.
Mice
Eight to ten week old BALB/c mice (Division of Cancer Therapeu-
tics, National Cancer Institute, MD) were used in all experiments.
Mice received intranasal inocula (50 μL) at various titers (determined
by TCID50 assay (Percopo et al., 2011)) while under isoﬂurane
anesthesia and were likewise anesthetized prior to sacriﬁce via
cervical dislocation. All protocols were evaluated and approved as
per the National Institutes of Allergy and Infectious Diseases Animal
Study Protocol LAD 8E and carried out in accordance with the
Institute's Animal Care and Use Committee Guidelines.
Viruses
PVM strain J3666 (105 TCID50 units/mL; Supp. Fig. 2) was main-
tained by mouse passage. PnV–Ane4/114296-08-NY (Renshaw et al.,
2010, 2011) and new PnVs were isolated from respiratory secretions
of mixed-breed dogs or cats with signs and symptoms of respiratory
disease (Supplemental Table 1). Mouse-passaged stocks of 114378-10-
29 KY-F, and 7968-11-OK were prepared and were evaluated by
TCID50 assay as previously described (Percopo et al., 2011), with titers
determined to be 2105 and 5104 TCID50 units/mL, respectively.
Virus heat-inactivation was achieved by three serial freeze (dry-ice)
and heat (95 1C) cycles, a process previously shown to inactivate PVM
(Gabryszewski et al., 2011).
Quantitative RT-PCR
RNA was prepared from lung tissue from infected mice as
previously described (Gabryszewski et al., 2011). Virus copy number
per copy GAPDH was determined by a dual standard curve
quantitative PCR method (Renshaw et al., 2011; Gabryszewski
et al., 2011) modiﬁed so that primers and probe would detect all
PnV isolates in use in our experiments: pnv-F-primer 5′-GTT ATC
AAC ACA GTG TGT GCG C-3′, pnv-RV-primer 5′-CTG ATG TAG CAA
Fig. 6. Histopathology and neutrophil recruitment. ((A)–(D)) Hematoxylin and eosin (H&E) stained ﬁxed lung tissue from mice at day 7 after inoculation with 50 TCID50
units PnV 114378-10-29KY-F ((A), (C)) or 90 TCID50 units PnV 7968-11-OK ((B), (D)) at original magniﬁcations 10 ((A), (B)) or 40 ((C), (D)). (E) Percent (%) neutrophils in
bronchoalveolar lavage (BAL) ﬂuid from mice inoculated with 50 TCID50 units active or heat-inactivated PnV 114378-10-29KY-F or PnV 7968-11-OK at day 7 after inoculation,
n¼5–6 mice per group, *po0.05, **po0.01 Mann–Whitney U-test.
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TAMRA. We have documented clear correlation between virus
detection by this method and by TCID50 (Supplemental Fig. 2).
Detection of IFN-β was carried out using the 20X concentrated
primer-probe set from ABI Assay by Design (Mm00439546_s1) used
as per manufacturer's instructions (ABI, Columbia, MD). IFN-β
expression was normalized to GAPDH as previously described
(Gabryszewski et al., 2011).
Proinﬂammatory cytokine detection
At selected time points, lungs from mice challenged either with
heat-inactivated or actively-replicating PnV variants were collectedand blade-homogenized into 1 mL of PBS plus 0.1% BSA. Homoge-
nates were clariﬁed by centrifugation and supernatants were eval-
uated by ELISA (R&D Systems, Minneapolis, MN). Values obtained
were normalized for total protein (BCA Assay, Pierce, Rockford, IL).
Neutrophil recruitment
On day 7 post-inoculation, neutrophils were evaluated in
bronchoalveolar lavage (BAL) ﬂuid from mice challenged either
with heat-inactivated (hi) PnV or actively-replicating PnV variants
using modiﬁed Giemsa staining (Diff-Quik; Fisher Scientiﬁc, Pitts-
burgh, PA). To prepare cells for staining, BAL ﬂuids were subjected
to centrifugation and resuspended in 100–200 mL PBS plus 0.1%
Fig. 7. Evolutionary analysis. Comparison of non-synonymous (dN) and synon-
ymous (dS) substitution rates for individual PVM/PVM (black symbols), PnV/PnV
(grey symbols) and PVM/PnV (white symbols); broken line, dN/dS¼1.0 as described
in the text. (A) G gene and (B) F gene sequence pairs; Genbank nos. for all
sequences listed in legend to Fig. 1.
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Cytospin apparatus (Thermo-Electron, Pittsburgh, PA). Following
staining and mounting of cells, 10 high-power ﬁelds were visually
inspected by light microscopy.
Lung histopathology
Prior to excision of lungs from the chest cavity, excess blood
was removed by perfusion via the right ventricle with PBS, and the
lungs from mice challenged with either heat-inactivated PnV or
actively-replicating PnV variants were inﬂated transtracheally
using 250 μL 10% phosphate buffered formalin. The heart and the
lungs were removed and ﬁxed overnight in 10% phosphate
buffered formalin at 4 1C. Samples were parafﬁn-embedded, sec-
tioned, and stained with hematoxylin and eosin (Histoserv,
Germantown, MD).
Statistical, sequence and evolutionary analysis
Sequences were aligned with ClustalW (http://www.genome.
jp/tools/clustalw/). Phylogenetic analysis was conducted using
Molecular Evolutionary Genetics Analysis 4.0, which infers the
evolutionary tree by the Neighbor-Joining (NJ) algorithm; details
in the ﬁgure legends (Tamura et al., 2007). Data were evaluated
using Mann–Whitney U test, Kruskal–Wallis one-way analysis of
variance (ANOVA) with Dunn's multiple comparison test or two-
way ANOVA with Bonferroni's multiple comparison tests, as
appropriate. All statistical tests were included in the GraphPad
Prism 5 software package (GraphPad Software, La Jolla, CA).
Grubbs’ test was performed to detect outliers.Acknowledgments
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